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Impact of sleepiness on arterial
stiffness and cardio-vascular
the  median  SCORE  CV  risk  was  2  (0--5),  26  out  of  33  patients
had  moderate  CV  risk.c
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Obstructive  sleep  apnea  (OSA),  if  left  untreated,  is  associ-
ated  with  high  cardio-vascular  (CV)  morbidity  and  mortality.
Based  on  large-scale  epidemiological  studies,  it  is  known
that  excessive  sleepiness  is  a  cardinal  symptom  but  the
majority  of  individuals  with  high  Apnea  Hypopnea  Index
(IAH)  do  not  complain  of  it.1,2
Arterial  stiffness,  evaluated  by  pulse  wave  velocity
(PWV),  has  a  predictive  value  for  CV  events,  beyond
classical  risk  factors,  and  can  be  considered  as  an  inter-
mediate  endpoint  for  CV  events.  Carotid-femoral  pulse
wave  velocity  (cf-PWV)  remains  the  most  commonly
used  non-invasive  method  and  is  considered  as  the  gold
standard.3
Increased  PWV  is  associated  with  various  conditions,  of
which  age  and  blood  pressure  (BP)  are  the  most  important.
In  OSA  cf-PWV  value  is  augmented,  with  improvement  after
treatment  with  CPAP.4,5
In  order  to  explore  the  association  of  sleepiness  with  CV
risk  in  patients  with  OSA,  we  conducted  a  prospective  study
of  consecutive  males,  younger  than  65  years  old,  referred
for  snoring  or  OSA  related  symptoms.  They  were  included
if  they  had  moderate  to  severe  OSA  (AHI  >  15)  diagnosed  by
cardiorespiratory  polygraphic  study,  level  3,  in  our  institu-
tion’s  sleep  laboratory,  and  excluded  if  they  had  other  sleep
disturbances,  diabetes  or  CV  disease  beyond  hypertension.
Epworth  Sleepiness  Scale  (ESS)  score  >  10  deﬁned  excessive
sleepiness.  Patients  with  high  BP  in  24  h  monitoring  (ABPM)
or  already  taking  antihypertensive  drugs  were  considered
hypertensive.  Arterial  stiffness  was  assessed  by  cf-PWV,  and
10  m/s  was  used  as  threshold  value.  CV  risk  was  calculated
by  SCORE  --  European  Low  Risk  Chart.
Univariable  logistic  regression  and  stratiﬁed  Mantel--
Haenszel  analyses  were  performed  to  quantify  associations
between  variables.
From  approximately  700  patients  referred  to  the  Clinic
during  the  study,  34  patients  were  recruited,  with  median
age  53.0  years;  24  (70.6%)  were  hypertensive  (15  with  med-
ication),  18  (52.9%)  had  metabolic  syndrome  and  30  (91%)
had  dyslipidaemia.  The  cf-PWV  was  high  in  27  (79.4%)  and
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f-PWV  was  signiﬁcantly  higher  when  OSA  was  severe  rather
han  moderate  OSA  (p  =  0.047).  In  fact,  weak  evidence  was
ound  that  the  odds  for  high  cf-PWV  increase  with  either
ncreasing  AHI  (OR  1.08;  95%CI  0.99--1.18;  p  =  0.078)  or  ODI
OR  1.14;  95%CI  0.98--1.32;  p  =  0.086).  No  association  was
ound  between  cf-PWV  and  ABPM  measurements.
Patients  with  high  cf-PWV  also  had  similar  prevalence
ates  of  arterial  hypertension  (57.1%  [95%  CI  25.05--84.18]
s.  74.1%  [95%  CI  55.32--86.83];  p  =  0.394)  but  higher  SCORE
V  risk  (median  (maximum)  1  (2)  vs.  3  (5);  p =  0.029).
Excessive  sleepiness  was  diagnosed  in  10  (29.4%)  patients
hich  had  signiﬁcantly  higher  AHI,  ODI  and  higher  SaO2 < 90%
ut  lower  minimum  SaO2 than  non-sleepy  patients  (Table  1).
Sleepy  and  non-sleepy  patients  did  not  differ  in  preva-
ence  rates  of  hypertension  (70.0%  vs.  70.8%)  or  average
P  values.  However,  all  patients  with  normal  average  ABPM
alues  under  medication  were  non-sleepy.  Both  cf-PWV  and
CORE  CV  risk  were  similar  regarding  sleepiness  (median
maximum)  2  (4)  vs.  2  (5);  p  =  0.764).  A  weak  evidence  was
ound  of  a  better  control  of  BP  with  medication  in  non-sleepy
atients,  based  on  the  ABPM  values  (Mantel--Haenszel,
 =  0.091).
Other  authors  reported  similar  relationships  between
leepiness  and  cf-PWV  in  OSA.  Drager  et  al.6 made  an  obser-
ational  study  of  patients  with  metabolic  syndrome,  and
ohler  et  al.7 used  a  different  arterial  stiffness  index.
In  this  sample  of  male  patients  without  signiﬁcant  comor-
idities,  who  are  suspected  by  their  primary  care  physician
f  having  OSA  and  needing  treatment,  a  high  prevalence  of
rterial  hypertension  was  found,  common  in  OSA;  It  should
e  noted  that  in  25%  of  the  sample  it  was  previously  undiag-
osed  and  in  80%  of  the  patients  under  drug  therapy,  it  was
ncontrolled.  High  BP  was  present  regardless  of  sleepiness,
ut  in  non-sleepy  patients  it  may  be  easier  to  control  with
edication.
This  analysis  had,  as  limitations,  the  small  number  of
atients  and  the  exclusion  of  patients  with  mild  OSA,  older
atients  or  those  patients  with  serious  comorbidities.
In  conclusion,  sleepy  patients  have  more  severe  OSA,
hey  tend  to  be  more  hypertensive  and  have  uncontrolled
P,  but  arterial  stiffness  and  CV  risk  are  similar  in  regard  of
leepiness.
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Table  1  Clinical  characteristics  of  the  participants,  classiﬁed  by  sleepiness  group.  Values  are  median  and  interquartile  range
(IQR).
Sleepy  (n  =  10)  Non-sleepy  (n  =  24)  p-Value
Epworth  13  (11.8--14.0)  5.5  (4.0--7.0)  p  <  0.001
Age (years)  54.0  (47.0--57.3)  53.0  (46.3--59.0)  ns
BMI (kg/m2)  31.5  (27.6--32.9)  29.7  (26.8--34.5)  ns
Waist (cm)  104.5  (94.8--105.3)  100.0  (94.8--115.8)  ns
Mean SaO2 (%)  92.3  (90.8--93.7)  93.5  (92.0--94.5)  ns
Minimum SaO2 (%) 70.5  (68.3--76.3) 81.5  (74.8--84.0) 0.031
SaO2 <  90%  (%) 13.5  (7.4--28.1) 5.5  (2.1--16.5) 0.042
ODI (events/h) 32.9  (13.4--46.1) 12.2  (6.6--22.6) 0.034
AHI (events/h)  46.9  (23.7--52.3)  21.9  (16.1--36.5)  0.018
24-h SBP,  mmHg  127.5  (119.8--138.3)  127.0  (121.0--136.5)  ns
24-h DBP,  mmHg  85.5  (74.3--88.3)  80.5  (74.0--85.8)  ns
Daytime SBP  (mmHg)  133.5  (125.3--142.3)  131.0  (124.3--138.3)  ns
Daytime DBP  (mmHg) 88.0  (78.3--90.3) 82.0  (75.5--88.5) ns
Night-time SBP  (mmHg) 109.5  (104.0--126.3) 116.5  (109.0--124.8) ns
Night-time DBP  (mmHg) 68.5  (64.5--78.5) 71.0  (61.3--75.8) ns
cf-PWV (m/s) 11.5  (10.9--12.8) 11.1  (10.1--11.9) ns
Epworth -- Epworth Sleepiness Scale; BMI -- body mass index; SaO2 -- arterial oxygen saturation; SaO2 < 90% -- time under 90%; ODI --
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5oxygen desaturation index; AHI -- Apnoea-Hypopnoea Index; SBP -- systolic blood pressure; DBP -- diastolic blood pressure; cf-PWV --
carotid-femoral pulse wave velocity.
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